| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 03/16/1998 | CA2215655A1 Use of 8,9-dehydroestrone as an estrogen with neutral effects on prolactin levels |
| 03/12/1998 | WO1998009992A2 HTm4, METHODS OF TREATMENT AND ASSAYS, AGONISTS AND ANTAGONISTS |
| 03/12/1998 | WO1998009985A2 Anti-inflammatory peptides and uses thereof |
| 03/12/1998 | WO1998009948A2 Nitric ester derivatives and their use in urinary incontinence and other diseases |
| 03/12/1998 | WO1998009626A1 Methods for in vivo reduction of iron levels and compositions useful therefor |
| 03/12/1998 | WO1998009625A1 SELECTIVE β3 ADRENERGIC AGONISTS |
| 03/12/1998 | CA2592537A1 Nitric ester derivatives in the treatment of inflammatory diseases |
| 03/12/1998 | CA2264490A1 Htm4, methods of treatment and assays, agonists and antagonists |
| 03/12/1998 | CA2264285A1 Anti-inflammatory peptides and uses thereof |
| 03/12/1998 | CA2264081A1 Nitric ester derivatives and their use in urinary incontinence and other diseases |
| 03/12/1998 | CA2263686A1 Methods for in vivo reduction of iron levels and compositions useful therefor |
| 03/12/1998 | CA2215015A1 Treating prostate hypertrophy and prostate cancer |
| 03/11/1998 | EP0827959A2 Benzo[B]thiophene compounds, intermediates, processes, compositions, and methods |
| 03/11/1998 | EP0827746A1 Carbazole analogues as selective B3 adrenergic agonists |
| 03/11/1998 | EP0827511A1 Agents for binding to advanced glycosylation endproducts, and methods of their use |
| 03/11/1998 | EP0827505A1 Selected soluble esters of hydroxyl-containing indolocarbazoles |
| 03/11/1998 | EP0827408A1 Method of administration of igf-i |
| 03/11/1998 | EP0827401A2 Methods and compositions for inhibiting alpha-reductase activity |
| 03/11/1998 | EP0696919A4 Diagnosis and treatment of erectile dysfunction |
| 03/11/1998 | EP0636125B1 Basic derivatives of glutamic acid and aspartic acid as gastrin or cholecystokinin antagonists |
| 03/10/1998 | US5726205 O-acyl-4-phenyl-cyclohexanols, their salts, medicaments containing such compounds and their use, as well as a method of preparing them |
| 03/10/1998 | US5726196 Aromatase-inhibiting composition containing azole derivative |
| 03/10/1998 | US5726156 Cytokine regulatory agents and methods of use in pathologies and conditions associated with altered cytokine levels |
| 03/10/1998 | US5726149 Treatment of glomerulonephritis with decorin |
| 03/05/1998 | WO1998008850A1 Spirocyclic metalloprotease inhibitors |
| 03/05/1998 | WO1998008847A1 Substituted 6,5-hetero-bicyclic derivatives |
| 03/05/1998 | WO1998008846A1 Substituted 6,6-hetero-bicyclic derivatives |
| 03/05/1998 | WO1998008834A1 Benzylamine derivatives, their preparation and their application in therapeutics |
| 03/05/1998 | WO1998008826A1 Piperazino derivatives as neurokinin antagonists |
| 03/05/1998 | WO1998008533A1 Sustained peptide-release formulation |
| 03/05/1998 | WO1998008532A1 Methods of treating renal disease with a gastrin releasing peptide receptor antagonist |
| 03/05/1998 | WO1998008529A1 Method of inhibiting fibrosis with a somatostatin agonist |
| 03/05/1998 | WO1998008528A1 Method of inhibiting fibrosis with a somatostatin agonist |
| 03/05/1998 | WO1998008515A1 Tablet with controlled release of alfuzosine chlorydrate |
| 03/05/1998 | WO1998008503A1 Therapeutic methods and compositions involving isoflavones |
| 03/05/1998 | WO1998008480A2 Method of using tetracycline compounds for inhibition of nitric oxide production |
| 03/05/1998 | WO1997037688A3 Pharmaceutical combination containing a compound having angiotensin ii and antagonistic activity |
| 03/05/1998 | CA2670296A1 Method of using tetracycline compounds for inhibition of nitric oxide production |
| 03/05/1998 | CA2265049A1 Therapeutic methods and compositions involving isoflavones |
| 03/05/1998 | CA2264309A1 Method of inhibiting fibrosis with a somatostatin agonist |
| 03/05/1998 | CA2264044A1 Spirocyclic metalloprotease inhibitors |
| 03/04/1998 | EP0826774A2 Staphylococcal Fab I enoyl-ACP reductase |
| 03/04/1998 | EP0826680A1 Dihydronaphthalene and naphthalene compounds, intermediates, formulations, and methods |
| 03/04/1998 | EP0826670A1 Naphthalene compounds, intermediates, formulations, and methods |
| 03/04/1998 | EP0825993A1 Xanthines and their therapeutic use |
| 03/04/1998 | EP0700293B1 Dihydrotestosterone for use in androgenotherapy |
| 03/04/1998 | CN1175260A Induction of cytotoxic t -lymphocyte responses |
| 03/04/1998 | CN1174836A Novel imino derivatives as inhibitors of bone resorption and vitronectin receptor antagonists |
| 03/04/1998 | CN1174833A Phenyl substituted alkenocarboxylic guanidine, preparation method, application as medicine or diagnostic agent adn medicine containing it |
| 03/04/1998 | CN1174709A Traditional Chinese set prescription for curing gastrointestinal tract disease and gynopathy |
| 03/03/1998 | US5723484 Benzopyran compounds as 5-HT2C receptor antagonists |
| 03/03/1998 | US5723456 Therapeutic treatment for cardiovascular diseases |
| 03/03/1998 | US5723441 Method of treating renal disease by administering IGF-I and IGFBP-3 |
| 02/28/1998 | CA2213814A1 Naphthalene compounds, intermediates, formulations, and methods |
| 02/26/1998 | WO1998007841A1 Embryonic or stem-like cell lines produced by cross species nuclear transplantation |
| 02/26/1998 | CA2262817A1 Embryonic or stem-like cell lines produced by cross species nuclear transplantation |
| 02/25/1998 | EP0825260A2 Arginase II |
| 02/25/1998 | EP0825180A1 1-omega-(3,4-dihydro-2-naphthalenyl)alkyl] cyclic amine derivatives, process for producing the same, and medicinal composition containing the same |
| 02/25/1998 | EP0825178A1 Phenyl-substituted alkenoylguanidides, process for their preparation, their use as drugs or in diagnostic agents and drugs containing them |
| 02/25/1998 | EP0824910A2 Use of a Krill Enzyme for the Treatment of Dental Plaque |
| 02/25/1998 | EP0824530A1 Aryl glycinamide derivatives, methods of producing these substances and pharmaceutical compositions containing such compounds |
| 02/25/1998 | EP0824519A1 Beta-adrenergic agonists |
| 02/25/1998 | CN1174508A Improvement in or relating to endometrial function |
| 02/25/1998 | CN1174493A Amelioration of human erectile dysfunction by treatment with iNOS, and related NOS agents |
| 02/25/1998 | CN1037512C Imidazolyl-substituted cyclohexane derivatives, prep. and use thereof |
| 02/24/1998 | US5721238 2,8-disubstituted quinazolinones |
| 02/24/1998 | CA2086919C Process for the production of unsaturated 17.alpha.-cyanomethyl -17.beta. hydroxy steroids |
| 02/19/1998 | WO1998006844A1 Keratinocyte growth factor-2 (kgf-2 or fibroblast growth factor-12, kgf-12) |
| 02/19/1998 | WO1998006262A1 Il-8 receptor antagonists |
| 02/19/1998 | WO1997044356A3 Ret ligand (retl) for stimulating neural and renal growth |
| 02/19/1998 | CA2263143A1 Keratinocyte growth factor-2 (kgf-2 or fibroblast growth factor-12, fgf-12) |
| 02/18/1998 | EP0823906A1 Piperazino derivatives as neurokinin antagonists |
| 02/18/1998 | EP0823895A1 Fatty acid esters as bioactive compounds |
| 02/18/1998 | EP0823889A1 1,3-propane diol derivatives as bioactive compounds |
| 02/18/1998 | EP0609217B1 Dry starch-iodine pharmaceutical formulations |
| 02/18/1998 | EP0561939B1 Use of angiotensin ii receptor antagonists in the treatment of diabetic nephropathy |
| 02/18/1998 | CN1173817A Method, compsns and kits for increasing the oral bioavilability of pharmaceuticalagents |
| 02/17/1998 | US5719278 Tricyclic benzazepine vasopressin antagonists |
| 02/17/1998 | US5719180 Chroman derivatives having vitamin E-like activities |
| 02/17/1998 | US5719173 Administering a benzimidazole carboxylate |
| 02/17/1998 | US5719169 Substituted benzoylguanidines, their use as a medicament or diagnostic, and medicament containing them |
| 02/17/1998 | US5719165 Methods of inhibiting ovarian dysgenesis, delayed puberty, or sexual infantilism |
| 02/17/1998 | US5719138 Contacting with a dicitrate cyclic diester |
| 02/17/1998 | US5718917 PGE-1 containing lyophilized liposomes for use in the treatment of erectile dysfunction |
| 02/17/1998 | US5718865 Shaping a graunlated alum and plasticizer mixture |
| 02/17/1998 | CA1339679C Reduced size lhrh analogs |
| 02/12/1998 | WO1998005349A1 A novel method of detecting and treating cancer |
| 02/12/1998 | WO1998005335A1 PURINE INHIBITORS OF CYCLIN DEPENDENT KINASE 2 AND IλB-$g(a) |
| 02/12/1998 | WO1998005317A1 Il-8 receptor antagonists |
| 02/12/1998 | CA2262624A1 A novel method of detecting and treating cancer |
| 02/11/1998 | EP0823478A2 Human cartilage gp 39-like gene |
| 02/11/1998 | EP0823437A2 8-Substituted B-nor-6-thiaequilenin compounds having activity as selective estrogen receptor modulators |
| 02/11/1998 | EP0822942A1 Modified anti-icam-1 antibodies and their use in the treatment of inflammation |
| 02/11/1998 | EP0822826A1 Nitrosylated neuropeptides |
| 02/11/1998 | EP0822814A1 ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTS |
| 02/11/1998 | EP0624164B1 Peptides with organo-protective activity, process for their preparation and their use in the therapy |
| 02/11/1998 | CN1173132A Dihydropyrimidines and uses thereof |
| 02/10/1998 | US5717088 Method of making steroid derivatives for the treatment of prostatic hypertrophy |
| 02/10/1998 | US5716994 Plant extracts |
| 02/10/1998 | US5716986 Lipoxygenase inhibitors |